Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000109 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 4, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
40,732
Total Value
$2,392,570.92
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Sep 1, 2026 | Exercise/Conversion | 7,500 | $14.50 | $108,750.00 | 105,494 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Sep 1, 2026 | Sale | 900 | $86.25 | $77,625.00 | 104,594 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Sep 1, 2026 | Sale | 4,384 | $87.11 | $381,890.24 | 100,210 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Sep 1, 2026 | Sale | 2,016 | $88.03 | $177,468.48 | 98,194 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Sep 1, 2026 | Sale | 200 | $89.04 | $17,808.00 | 97,994 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Sep 2, 2026 | Sale | 18,232 | $89.35 | $1,629,029.20 | 79,762 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Exercise/Conversion | 7,500 | $0.00 | $0.00 | 337,357 | Direct | โ | View Details |